NATCHITOCHES REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
NATCHITOCHES REGIONAL MEDICAL CENTER is a 81-bed under-performing / distressed in NATCHITOCHES PARISH, LA with $82.4M in net patient revenue and a -21.8% operating margin. The hospital serves a payer mix of 24.9% Medicare, 1.1% Medicaid, and 74.1% commercial.
Thesis: Turnaround. Our ML models identify $6.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.8% to -14.5% (+736bps).
| Net Revenue HCRIS | $82.4M |
| Current EBITDA COMPUTED | $-18.0M |
| Operating Margin COMPUTED | -21.8% |
| Occupancy HCRIS | 22.8% |
| Revenue / Bed COMPUTED | $1.0M |
| Net-to-Gross HCRIS | 28.4% |
| Distress Probability ML | 53.6% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -21.8% places it below the state median. Among 50 size-comparable peers (40-162 beds), the median margin is -3.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (40-162), prioritizing same-state peers. 50 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NATCHITOCHES REGIONAL MEDICAL (Target) | LA | 81 | $82.4M | -21.8% |
| TERREBONNE GENERAL HEALTH SYST | LA | 139 | $230.6M | -8.3% |
| OCHSNER MEDICAL CENTER - KENNE | LA | 115 | $193.8M | -2.9% |
| ST. PATRICK HOSPITAL | LA | 100 | $189.4M | -7.4% |
| OPELOUSAS GENERAL HOSPITAL | LA | 151 | $168.5M | -12.7% |
| UNIVERSITY HOSPITAL & CLINICS | LA | 52 | $158.9M | -33.4% |
| OCHSNER MEDICAL CENTER -NORTHS | LA | 150 | $107.3M | -5.7% |
| IBERIA MEDICAL CENTER | LA | 133 | $107.0M | 1.3% |
| SOUTHERN REGIONAL MEDICAL CORP | LA | 64 | $97.3M | -50.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $53K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-18.0M |
| + RCM Uplift | +$6.1M |
| Pro Forma EBITDA | $-11.9M |
| Current Margin | -21.8% |
| Pro Forma Margin | -14.5% |
| WC Released (1x) | $3.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-27.7M | $-58.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-27.7M | $-72.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-24.9M | $-61.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-24.9M | $-74.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-30.5M | $-79.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-30.5M | $-97.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 22.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 50 hospitals with 40-162 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-25.1% / P50=-3.1% / P75=4.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.